Corporate costs cannot be extrapolated. If you read the 4C, $2.7m last quarter was non-recurring relating to the Imbio acquisition. In the Dec 2023 quarter, they would have incurred further non-recurring costs for the Imbio DD and agreements etc too.
- Forums
- ASX - By Stock
- Ann: Quarterly Activity Report and Appendix 4C for Q3 FY2024
Corporate costs cannot be extrapolated. If you read the 4C,...
Featured News
Add 4DX (ASX) to my watchlist
(20min delay)
|
|||||
Last
58.3¢ |
Change
-0.008(1.27%) |
Mkt cap ! $227.0M |
Open | High | Low | Value | Volume |
56.0¢ | 58.5¢ | 56.0¢ | $251.0K | 438.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 901 | 58.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
58.5¢ | 29021 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1118 | 0.580 |
5 | 60275 | 0.575 |
6 | 13818 | 0.570 |
3 | 27619 | 0.565 |
4 | 51613 | 0.560 |
Price($) | Vol. | No. |
---|---|---|
0.585 | 29021 | 8 |
0.590 | 70257 | 2 |
0.595 | 7571 | 3 |
0.600 | 2000 | 1 |
0.605 | 25579 | 4 |
Last trade - 14.40pm 25/06/2024 (20 minute delay) ? |
Featured News
4DX (ASX) Chart |